Children with COVID-19 may have this rare inflammation disease

Credit: CC0 Public Domain

In a new study, researchers have mapped the immune response in children affected by a rare but life-threatening inflammatory syndrome associated with COVID-19.

The study shows that the inflammatory response differs from that in Kawasaki disease and severe acute COVID-19.

The research was conducted by a team at Karolinska Institutet and elsewhere.

In the current COVID-19 pandemic, with very few exceptions, children have presented with mild symptoms.

However, doctors have discovered a new, life-threatening hyper-inflammatory syndrome resembling Kawasaki disease and named Multisystem Inflammatory Syndrome in Children associated with COVID-19, MIS-C.

In this study, the researchers have worked out the immunological aspects of this rare condition.

They compared blood samples from 13 MIS-C-patients with samples from 28 Kawasaki disease patients collected from 2017 to 2018, prior to COVID-19.

The analyses also included samples from children with mild COVID-19.

The results show that MIS-C is truly a distinct inflammatory condition from Kawasaki disease, despite having some shared features.

The hyper-inflammation and cytokine storm detected in children with MIS-C is also different from that seen in adult patients with severe, acute COVID-19, which researchers recently described in another publication.

When comparing MIS-C to these other inflammatory states, the study found the differential frequency of specific immune cell populations, inflammatory cytokines, and chemokines in the blood.

Unlike children with Kawasaki disease and children with mild COVID-19, children who developed MIS-C were lacking IgG-antibodies to common cold coronaviruses.

The researchers also found several autoantibodies that target the body’s own proteins and that may contribute to the pathogenesis of MIS-C.

They are now also looking into genetic risk factors for developing MIS-C after SARS-CoV-2 infection.

The team says there is an urgent need to better understand why a small minority of children infected with SARS-CoV-2 develop MIS-C, and they are adding a piece to the puzzle.

Better knowledge of the pathogenesis is important for the development of optimal treatments that can dampen the cytokine storm and hopefully save lives, as well as for vaccine development to avoid MIS-C caused by vaccination.

One author of the study is Petter Brodin, a pediatrician, and researcher at the Department of Women’s and Children’s Health.

The study is published in Cell.

Copyright © 2020 Knowridge Science Report. All rights reserved.